68 filings
Page 3 of 4
8-K
qu8tiu
23 Feb 22
Regulation FD Disclosure
9:31am
8-K
uw1bi7
10 Feb 22
23andMe Reports FY2022 Third Quarter Financial Results
4:11pm
8-K
u37ssdz
18 Jan 22
Regulation FD Disclosure
8:15am
8-K
h5fqjr2xka cu
10 Jan 22
23andMe Receives FDA Clearance for Direct-to-Consumer Genetic Test on a Hereditary Prostate Cancer Marker
8:16am
8-K
ono85468fv66ni9ulnj
6 Jan 22
Regulation FD Disclosure
4:05pm
8-K
500pe i64i
28 Dec 21
23andMe Announces the Results of the Completed Redemption of All Outstanding Warrants
4:16pm
8-K
yfrwvfik9czq2dxa4lay
22 Nov 21
23andMe Announces Redemption of All Outstanding Warrants
4:31pm
8-K
2e6gsasvth7
10 Nov 21
Results of Operations and Financial Condition
4:11pm
8-K
tbordei pc
9 Nov 21
23andMe Announces Appointment of Dr. Sandra Hernández to Board of Directors
4:06pm
8-K
skxxyz
2 Nov 21
23andMe Announces the Closing of its Acquisition of Lemonaid Health
8:02am
8-K
ioy15on aj0
22 Oct 21
23andMe Agrees to Acquire Lemonaid Health
4:05pm
8-K
69ynhlco
10 Sep 21
Regulation FD Disclosure
7:02am
8-K
e6iv5 mzhzl
13 Aug 21
23andMe Reports FY2022 First Quarter Financial Results
7:13am
8-K/A
t4ndohna dcp4npt5w5p
21 Jun 21
Material Modifications to Rights of Security Holders
8:32am
8-K
je9ngthpdr9wqq
21 Jun 21
Index to Consolidated Financial Statements
8:31am
8-K
6oromc22
11 Jun 21
Departure of Directors or Certain Officers
5:28pm
8-K
oj9xc6
4 Jun 21
Other Events
5:06pm
8-K
pjy6xwqbpifioci
28 May 21
VG Acquisition Corp. Receives Expected Notification from NYSE Related to Delayed Quarterly Report
5:15pm
8-K
mnuhz8jphl3i60tmq
27 May 21
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
in62qlylqy68owzwpeg8
3 May 21
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:23pm